$1.68 Million is the total value of Artal Group S.A.'s 120 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 74.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | Sell | BEIGENE LTDsponsored adr | $108,053 | -18.1% | 501,335 | -16.4% | 6.42% | -12.8% |
| MORF | Sell | MORPHIC HLDG INC | $68,277 | +18.7% | 1,813,949 | -15.6% | 4.06% | +26.4% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $57,172 | -31.2% | 1,537,709 | -16.1% | 3.40% | -26.7% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $46,779 | -10.1% | 1,817,349 | -9.1% | 2.78% | -4.3% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $39,108 | -19.9% | 3,526,407 | -11.8% | 2.32% | -14.7% |
| VOR | Sell | VOR BIOPHARMA INC | $15,025 | -21.4% | 2,792,805 | -2.9% | 0.89% | -16.3% |
| REPL | Sell | REPLIMUNE GROUP INC | $8,830 | -53.6% | 500,000 | -28.6% | 0.52% | -50.6% |
| AMAM | Sell | AMBRX BIOPHARMA INCsponsored ads | $6,264 | +28.2% | 702,291 | -67.4% | 0.37% | +36.3% |
| BEKE | Sell | KE HLDGS INCsponsored ads | $5,181 | -25.8% | 275,000 | -45.0% | 0.31% | -21.0% |
| GOSS | Sell | GOSSAMER BIO INC | $3,815 | -45.8% | 3,028,171 | -6.7% | 0.23% | -42.2% |
| TALS | Sell | TALARIS THERAPEUTICS INC | $1,719 | -18.4% | 914,262 | -55.7% | 0.10% | -13.6% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $317 | -98.9% | 1,747 | -98.8% | 0.02% | -98.8% |
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -200,000 | -100.0% | -0.00% | – |
| CFRX | Exit | CONTRAFECT CORP | $0 | – | -1,500,000 | -100.0% | -0.01% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -224,675 | -100.0% | -0.01% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -1,000,000 | -100.0% | -0.01% | – |
| NEXI | Exit | NEXIMMUNE INC | $0 | – | -1,200,000 | -100.0% | -0.02% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -450,000 | -100.0% | -0.02% | – |
| PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -2,000 | -100.0% | -0.02% | – |
| APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.02% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -260,500 | -100.0% | -0.04% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCsponsored ads | $0 | – | -1,803,858 | -100.0% | -0.04% | – |
| TSLA | Exit | TESLA INC | $0 | – | -6,300 | -100.0% | -0.04% | – |
| IGMS | Exit | IGM BIOSCIENCES INCcall | $0 | – | -50,000 | -100.0% | -0.05% | – |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -750,000 | -100.0% | -0.06% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCsponsored ads | $0 | – | -1,500,000 | -100.0% | -0.06% | – |
| APTX | Exit | APTINYX INC | $0 | – | -6,116,493 | -100.0% | -0.10% | – |
| IMMP | Exit | IMMUTEP LTDsponsored ads | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.11% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -1,000,000 | -100.0% | -0.11% | – |
| GRPH | Exit | GRAPHITE BIO INC | $0 | – | -700,000 | -100.0% | -0.13% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.13% | – |
| LYEL | Exit | LYELL IMMUNOPHARMA INC | $0 | – | -700,000 | -100.0% | -0.14% | – |
| OTLY | Exit | OATLY GROUP ABsponsored ads | $0 | – | -1,500,000 | -100.0% | -0.15% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -1,200,000 | -100.0% | -0.16% | – |
| Exit | EXSCIENTIA PLCads | $0 | – | -550,000 | -100.0% | -0.16% | – | |
| Exit | MIRION TECHNOLOGIES INC | $0 | – | -500,000 | -100.0% | -0.18% | – | |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -450,000 | -100.0% | -0.20% | – |
| Exit | AURA BIOSCIENCES INC | $0 | – | -410,000 | -100.0% | -0.24% | – | |
| Exit | EQRX INC | $0 | – | -2,000,000 | -100.0% | -0.28% | – | |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -1,856,194 | -100.0% | -0.36% | – |
| Exit | BIOHAVEN LTD | $0 | – | -500,000 | -100.0% | -0.39% | – | |
| RXRX | Exit | RECURSION PHARMACEUTICALS INcl a | $0 | – | -960,204 | -100.0% | -0.41% | – |
| EVTCY | Exit | EVOTEC AGsponsored ads | $0 | – | -1,149,425 | -100.0% | -0.52% | – |
| INSM | Exit | INSMED INC | $0 | – | -500,000 | -100.0% | -0.56% | – |
| BEKE | Exit | KE HLDGS INCcall | $0 | – | -800,000 | -100.0% | -0.62% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -1,000,000 | -100.0% | -1.20% | – |
| BGNE | Exit | BEIGENE LTDcall | $0 | – | -100,000 | -100.0% | -1.23% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -1.26% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -3,700,000 | -100.0% | -1.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.